Efficacy and Safety Assessment of Beltavac® With Polymerized Extract of HDM
Phase 3
Recruiting
- Conditions
- House Dust Mite Allergy
- Interventions
- Biological: PlaceboBiological: House dust mites allergoid from Dermatophagoides pteronyssinus and Dermatophagoides farinae
- First Posted Date
- 2022-05-27
- Last Posted Date
- 2024-07-18
- Lead Sponsor
- Probelte Pharma S.L.U.
- Target Recruit Count
- 350
- Registration Number
- NCT05395689
- Locations
- 🇪🇸
Hospital Regional de Málaga, Malaga, Málaga, Spain
🇪🇸Hospital General de Granollers, Granollers, Barcelona, Spain
🇪🇸Hospital Clinico Universitario de Valencia, Valencia, Spain
Study to Assess the Safety and Effectiveness of Beltavac® Polymerized With Cat Dander
Completed
- Conditions
- Rhinoconjunctivitis With or Without Allergic Asthma
- First Posted Date
- 2019-12-23
- Last Posted Date
- 2023-05-11
- Lead Sponsor
- Probelte Pharma S.L.U.
- Target Recruit Count
- 34
- Registration Number
- NCT04207697
- Locations
- 🇪🇸
Campus de la Salud University Hospital, Granada, Andalucía, Spain
🇪🇸Quirón Malaga Hospital, Málaga, Malaga, Spain
🇪🇸Ciudad de Jaen Hospital, Jaén, Andalucía, Spain
Study to Assess the Safety and Effectiveness of Beltavac® Polymerized With Alternaria Alternata
Completed
- Conditions
- Rhinoconjunctivitis With or Without Allergic Asthma
- First Posted Date
- 2018-07-27
- Last Posted Date
- 2023-05-11
- Lead Sponsor
- Probelte Pharma S.L.U.
- Target Recruit Count
- 65
- Registration Number
- NCT03604718
- Locations
- 🇪🇸
Clínica de Alergia Mar Jiménez Lara, Talavera De La Reina, Toledo, Spain
🇪🇸University Hospital of Torrejon, Torrejón De Ardoz, Madrid, Spain
🇪🇸Universitary Hospital of Vic, Vic, Barcelona, Spain
© Copyright 2025. All Rights Reserved by MedPath